➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Dow
McKinsey
Moodys
Boehringer Ingelheim

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Patent: 8,197,366

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,197,366
Title:Ball bat including integral barrel features for reducing BBCOR
Abstract: A ball bat includes a barrel having one or more integral features for selectively stiffening regions of the barrel. The barrel may include an indented region forming a rib projecting inwardly into the barrel. Alternatively, one or more inwardly projecting lips may be formed on adjoining barrel sections that are bonded, welded, or otherwise attached to each other, such that an integral, internal rib is formed in the barrel. The internal rib stiffens the barrel, thus reducing the barrel\'s BBCOR. One or more integral ribs may be provided at any desired barrel locations for selectively limiting the barrel\'s performance without appreciably increasing the moment of inertia of the ball bat. In another embodiment, a joint, to which two barrel sections are bonded, welded, or otherwise attached, includes an inwardly projecting member that stiffens the barrel, thus reducing the barrel\'s BBCOR.
Inventor(s): Chauvin; Dewey (Simi Valley, CA), Montgomery; Ian (Simi Valley, CA), Chuang; Hsing-Yen (Simi Valley, CA), Filice; Gary (Moorpark, CA), Giannetti; William (Winnetka, CA)
Assignee: Easton Sports, Inc. (Van Nuys, CA)
Application Number:12/624,056
Patent Claims:see list of patent claims

Details for Patent 8,197,366

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Emergent Biosolutions Canada Inc. BAT botulism antitoxin heptavalent LIQUID 125462 1 2013-03-01   Start Trial Easton Sports, Inc. (Van Nuys, CA) 2040-01-29 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
McKesson
Moodys
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.